This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (3229) Mobile Health in Psychiatry (527) Web-based and Mobile Health Interventions (4018) Mobile Health (mhealth) (3464) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (2111)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46179, first published .
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

Authors of this article:

Eva Grasa1, 2 Author Orcid Image ;   Jussi Seppälä3, 4 Author Orcid Image ;   Anna Alonso-Solis2, 5 Author Orcid Image ;   Marianne Haapea4, 6, 7 Author Orcid Image ;   Matti Isohanni4 Author Orcid Image ;   Jouko Miettunen4, 6 Author Orcid Image ;   Johanna Caro Mendivelso8 Author Orcid Image ;   Cari Almazan8 Author Orcid Image ;   Katya Rubinstein9 Author Orcid Image ;   Asaf Caspi9 Author Orcid Image ;   Zsolt Unoka10 Author Orcid Image ;   Kinga Farkas10 Author Orcid Image ;   Judith Usall2, 11, 12 Author Orcid Image ;   Susana Ochoa2, 11, 12 Author Orcid Image ;   Shenja van der Graaf13 Author Orcid Image ;   Charlotte Jewell14 Author Orcid Image ;   Anna Triantafillou15 Author Orcid Image ;   Matthias Stevens16, 17 Author Orcid Image ;   Elisenda Reixach18 Author Orcid Image ;   Jesus Berdun19 Author Orcid Image ;   m-RESIST group20 ;   Iluminada Corripio2, 21 Author Orcid Image
Article Authors Cited by (7) Tweetations (14) Metrics

Journals

  1. Chukka A, Choudhary S, Dutt S, Bondre A, Reddy P, Tugnawat D, Rozatkar A, Mehta U, Manjunatha N, Keshavan M, Patel V, Math S, Kumar C, Thirthalli J, Bhan A, Torous J, Naslund J. Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities. Current Treatment Options in Psychiatry 2023;10(4):346 View
  2. Lo B, Durocher K, Charow R, Kimball S, Pham Q, Sockalingam S, Wiljer D, Strudwick G. Application of a Sociotechnical Framework to Uncover Factors That Influence Effective User Engagement With Digital Mental Health Tools in Clinical Care Contexts: Scoping Review. Journal of Medical Internet Research 2025;27:e67820 View
  3. Seppälä J, Grasa E, Alonso-Solis A, Roldan-Bejarano A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazán C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Reixach E, Berdun J, Usall J, Ochoa S, Corripio I, Jääskeläinen E. Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study. JMIR Human Factors 2025;12:e67659 View
  4. Fulford D, Correll C, Harvey P, Cohen A. Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning. Schizophrenia Bulletin 2025 View
  5. Xia W, Hau C, Burns J, Ryan S, Firth J, Linardon J, Torous J. Smartphone intervention apps for schizophrenia: A review of the academic literature and app stores. Schizophrenia Research 2025;285:204 View
  6. Lakhan S, Dorner-Ciossek C, Besedina O, Dickerson F, Hastedt C, Isla R, Kahn R, Lindenmayer J, Mehta R, Snipes C, Speier A, Tang W, Willis B, Fernandez J, von der Goltz C, Pratap A. Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial. JMIR Research Protocols 2025;14:e81293 View
  7. Ruiz-Grosso P, Macedo-Orrego L, Zevallos-Bustamante S, Li L. Changes in loss to follow-up among elderly patients with schizophrenia during the COVID-19 pandemic: A study from a specialized center in Peru. PLOS Mental Health 2025;2(12):e0000471 View